Orchestra BioMed, Inc.
We are a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine. Our partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products we help develop. Using this approach, we focus on advancing promising therapeutic solutions, such as Virtue SAB and BackBeat CNT, through late-stage clinical research and regulatory approvals, while our partners focus on leveraging their commercial expertise and existing infrastructure to bring our products to global markets quickly and efficiently.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2017
- Employees:
- 11-100
About Us
- Optimizing development and commercialization of product candidates by sharing of responsibilities, risks and rewards with partners
- Enhancing capital efficiencies by sharing costs and responsibilities with our partners
- Maximizing the potential of future profitability by creating multiple long-term royalty and revenue sharing arrangements with partners
Our Vision
Our Vision is to be a leader in bringing high-impact medical innovations to life through risk-reward sharing partnerships.
Pipeline
Our pipeline is comprised of innovative therapeutic products that have the potential for optimized value creation using our partnership-enabled business model.
Our flagship product candidates, Virtue SAB and BackBeat CNT, exemplify key criteria that characterize innovations optimized for strategic partnerships:
- Target large therapeutic device markets with significant unmet needs
- Provide high impact procedure-based solutions with rapid adoption potential
- Offer strategic and financial benefits to commercial partners